LIFECORE BIOMEDICAL, INC. Other Comprehensive Income (Loss), Net of Tax
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other Comprehensive Income (Loss), Net of Tax of $1.45 million for the 12-month period ending 2021-05-30, per its 10-K filed 2021-07-29.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2021-07-29
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-05-31 was -$1.98M.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for the quarter ending 2020-02-23 was -$411.00K.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for the quarter ending 2019-11-24 was $127.00K, a 67.11% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for the quarter ending 2019-08-25 was -$612.00K.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for fiscal 2021 was $1.45M.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for fiscal 2020 was -$2.87M.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for fiscal 2019 was -$1.08M, a 251.40% decline from fiscal 2018.
- LIFECORE BIOMEDICAL, INC. other comprehensive income (loss), net of tax for fiscal 2018 was $716.00K, a 65.74% increase from fiscal 2017.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2021-05-30 | $1.45M 10-K · filed 2021-07-29 | |||
| 2020-05-31 | -$1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | -$2.39M derived: sum of 2 quarters · filed 2021-07-29 | -$2.26M derived: sum of 3 quarters · filed 2021-07-29 | -$2.87M 10-K · filed 2021-07-29 |
| 2020-02-23 | -$411.00K 10-Q · filed 2020-04-03 | -$284.00K derived: sum of 2 quarters · filed 2020-04-03 | -$896.00K 10-Q · filed 2020-04-03 | -$1.37M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-11-24 | $127.00K 10-Q · filed 2020-04-03 | -$485.00K 10-Q · filed 2020-01-02 | -$961.00K derived: sum of 3 quarters · filed 2021-07-29 | -$1.56M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-08-25 | -$612.00K 10-Q · filed 2020-04-03 | -$1.09M derived: sum of 2 quarters · filed 2021-07-29 | -$1.68M derived: sum of 3 quarters · filed 2021-07-29 | -$1.61M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-05-26 | -$476.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | -$1.07M derived: sum of 2 quarters · filed 2021-07-29 | -$995.00K derived: sum of 3 quarters · filed 2021-07-29 | -$1.08M 10-K · filed 2021-07-29 |
| 2019-02-24 | -$595.00K 10-Q · filed 2020-04-03 | -$519.00K derived: sum of 2 quarters · filed 2020-04-03 | -$608.00K 10-Q · filed 2020-04-03 | -$375.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-11-25 | $76.00K 10-Q · filed 2020-04-03 | -$13.00K 10-Q · filed 2020-01-02 | $220.00K derived: sum of 3 quarters · filed 2020-08-14 | $567.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-08-26 | -$89.00K 10-Q · filed 2020-04-03 | $144.00K derived: sum of 2 quarters · filed 2020-08-14 | $491.00K derived: sum of 3 quarters · filed 2020-08-14 | $730.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-05-27 | $233.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $580.00K derived: sum of 2 quarters · filed 2020-08-14 | $819.00K derived: sum of 3 quarters · filed 2020-08-14 | $716.00K 10-K · filed 2020-08-14 |
| 2018-02-25 | $347.00K 10-Q · filed 2019-04-04 | $586.00K derived: sum of 2 quarters · filed 2019-04-04 | $483.00K 10-Q · filed 2019-04-04 | $485.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-11-26 | $239.00K 10-Q · filed 2019-01-07 | $136.00K 10-Q · filed 2019-01-07 | $138.00K derived: sum of 3 quarters · filed 2019-08-01 | $241.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-08-27 | -$103.00K 10-Q · filed 2018-10-05 | -$101.00K derived: sum of 2 quarters · filed 2019-08-01 | $2.00K derived: sum of 3 quarters · filed 2019-08-01 | $329.00K derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-05-28 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $105.00K derived: sum of 2 quarters · filed 2019-08-01 | $432.00K derived: sum of 3 quarters · filed 2019-08-01 | $432.00K 10-K · filed 2019-08-01 |
| 2017-02-26 | $103.00K 10-Q · filed 2018-04-05 | $430.00K derived: sum of 2 quarters · filed 2018-04-05 | $430.00K 10-Q · filed 2018-04-05 | |
| 2016-11-27 | $327.00K 10-Q · filed 2018-01-05 | $327.00K 10-Q · filed 2018-01-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |